Purchase Order W912CN24P0034
Award Date
5/17/24
Potential Completion Date
5/17/28
Potential Value
$167K
Funding Federal Agency
Medical Command
Contracting Federal Agency
RCO Hawaii 413th CSB
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
1 Jarrett White Rd, Honolulu, HI 96859, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $241,707.00 fixed-price purchase order contract was awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Illumina, Inc. to provide a 1-year NextSeq 2000 Silver Support Plan subscription, with 4 additional 1-year option periods, for a NextSeq 2000 DNA sequencing instrument. The contract does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing instruments and reagents that has previously supplied equipment and services to support...
This is a firm fixed price purchase order for $367,269.00 awarded by the Medical Command (MEDCOM) division of the U.S. Army to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a NextSeq 500 sequencing system, with an ultimate completion date of November 18, 2020. Illumina has provided similar sequencing systems and related products and services to various federal agencies like the NIH, CDC, USDA, and VA in the past. This award is not...
This is a firm fixed price delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $110,534.40 contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is issued under...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
This is a firm fixed price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has a ceiling value of $473,964.67 and is for the provision of various Illumina reagents, with a period of performance through October 28, 2015. This appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has a ceiling value of $80,917.66 and a period of performance through September 26, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a long history of supporting federal agencies such as the NIH, CDC, USDA,...
This is a $372,757 firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the provision of a NextSeq 500 sequencing system to support the USACEHR (U.S. Army Center for Environmental Health Research). The contract does not have a set-aside designation. Illumina has been awarded previous prime federal contracts and subcontracts to provide a range of...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...